SDS Biostatistics have a vast experience of observational studies based on electronic health records, and product and disease registers. We deliver interactive detailed RWE reports to ensure usability across all platforms. We guide and support our clients through the stages of study design, protocol, medical writing and publication. We closely collaborate with clinical experts and have strong ties with academic researchers in various fields. By using advanced analytical methods, we search for answers and insights to obtain evidence for our clients towards
- Real-world usage for safety and adverse events
- Comparator treatments to accelerate drug development
- Feasibility of clinical research and development
- Health economic modelling of social burden of therapeutic areas and economic value of treatment
Our RWE customers come from large international pharmaceutical companies, governmental institutions and academia, and the track record includes more than 25 large RWE projects for Big Pharma in 2014 – 2021.
